scholarly journals “I don’t want to take buprenorphine for the rest of my life”: Acceptance and Commitment Therapy for a Client Struggling to Reduce Low-Dose Buprenorphine (a Hermeneutic Single-Case Efficacy Design)

Author(s):  
Kate Shepherd ◽  
Beth Pritty ◽  
Anna Tickle ◽  
Nima Moghaddam

AbstractThe misuse of substances is often maintained by both physical and psychological factors. Opioid-substitution medications manage physical aspects of addiction; however, difficulties with emotional regulation and avoidance perpetuate continued substance misuse. In the UK, individuals who misuse substances are often excluded from mental health services, meaning these underlying difficulties are not addressed. Acceptance and Commitment Therapy (ACT) seeks to reduce emotional avoidance. A hermeneutic single-case efficacy design was used to evaluate the effects of ACT within drugs and alcohol service. Quantitative and qualitative data was critically analysed to understand factors involved in identified changes. Analysis recognised the client progressed towards two of three of their goals, related to motivation and anxiety. Their psychological flexibility also increased. ACT processes played a key role in this; however, the therapeutic relationship and psychopharmacological factors were also noted. Study limitations and clinical and research implications are discussed.

2017 ◽  
Vol 41 (S1) ◽  
pp. S410-S410
Author(s):  
R. Guijarro ◽  
M. Cerviño ◽  
P. Castrillo

Acceptance and commitment therapy (ACT) is a third-generation therapy that relates to human suffering as an inherent part of life in the human condition. Concerning personal values, ACT is focused on the acceptance of suffering, by doing away with the avoidance of things that cause us discomfort.The goal of the therapy is to make a person's reactions to suffering more flexible, working with the role of the symptoms rather than with the eliminating the symptoms themselves.This paper shows how the application of this therapy to a person with generalized anxiety disorder helps to reduce symptoms such as uncontrollable worrying, lack of concentration and muscular tension that these patients often suffer. The modification of symptoms has been measured by a single case study, where the symptoms are assessed by questionnaires before and after the treatment's application. Diagnosis was made according to the Diagnostic and Statistical Manual of Mental Disorders’ (DSM-IV) criteria.Disclosure of interestThe authors have not supplied their declaration of competing interest.


Background: The gastrointestinal tract, as one of the most important organs of the body, has its own diseases that involved many people. Therefore, the present study seeks to investigate the effectiveness acceptance and commitment therapy based on cognitive-emotional regulation and cognitive flexibility among gastrointestinal patients. Materials and Methods: The research method was quasi-experimental with pretest-posttest design with control group was unbalanced and the statistical population of this study was all gastrointestinal patients in Sari who referred to Imam Khomeini Hospital in 2020 and its sample included 30 people (15 people for the experimental group and 15 people for the control group), who were selected using the available sampling method. Then, the members of the experimental group were treated for 8 sessions based on acceptance and commitment and the control group did not receive any treatment. Research instruments included the Cognitive-Emotional Regulation Questionnaire (Garnowski et al, 2001) and Cognitive Flexibility (Dena and Venedrwal, 2010). And the statistical method of this research was multivariate analysis of covariance. Results: The results of multivariable covariance analysis showed that acceptance and commitment therapy was effective on cognitive-emotional regulation and cognitive flexibility and significantly improved cognitive-emotional regulation and cognitive flexibility in gastrointestinal patients. Conclusion: According to the research findings, acceptance and commitment therapy can be used as an effective method to promote cognitive-emotional regulation and cognitive flexibility in gastrointestinal patients.


2011 ◽  
Vol 12 (1) ◽  
pp. 54-70 ◽  
Author(s):  
Cheryl Soo ◽  
Robyn L. Tate ◽  
Amanda Lane-Brown

AbstractAcceptance and commitment therapy (ACT) is increasingly used in clinical practice to manage anxiety conditions. This psychotherapeutic approach focuses on the following: (1) acceptance of an individual's experience of the spectrum of psychological and emotional states, (2) choosing valued direction for the individual's life, and (3) commitment to action that leads the individual in the direction of those values. This article presents an empirical review of ACT for treatment of anxiety in two parts. In the first part we systematically review the literature for studies examining ACT for anxiety management in the general population with anxiety problems. In the second part, we discuss applicability of acceptance-based approaches for a health population in which these techniques may have applicability, that is, for people with acquired brain injury (ABI). Electronic searches for the review were conducted on PsycINFO and Medline. Inclusion criteria were as follows: (1) used an ACT intervention study, (2) the target of the intervention was an anxiety disorder or anxiety symptomatology, (3) the intervention used a randomised controlled trial (RCT) or single case experimental design (SCED) methodology, and (4) the paper was available in English. Studies were rated for methodological quality using standardised assessment procedures. Four RCTs provided support for ACT for obsessive compulsive disorder (OCD), maths anxiety, trichotillomania (TTM), and mixed anxiety and depression. Three SCED trials scoring in the high range on the scale of methodological quality revealed some support for ACT for managing TTM, skin picking, and OCD. Although no studies were identified that investigated ACT for managing anxiety in people with ABI, the review highlights issues for consideration when applying ACT in this population.


2018 ◽  
Vol 9 (6) ◽  
pp. 1076-1086 ◽  
Author(s):  
Roger Vilardaga ◽  
Javier Rizo ◽  
Richard K Ries ◽  
Julie A Kientz ◽  
Douglas M Ziedonis ◽  
...  

Abstract Despite public health efforts, individuals with serious mental illness (SMI) still have very high rates of tobacco smoking. Innovative approaches to reach this population are needed. These series of case studies aimed to descriptively evaluate the usability, user experience (UX), and user engagement (UE) of Learn to Quit (LTQ), an acceptance and commitment therapy smoking cessation app designed for people with SMI, and to compare it with an app designed for the general population, NCI (National Cancer Institute) QuitGuide (QG). Both apps were combined with nicotine replacement therapy and technical coaching. Inspired by the ORBIT model, we implemented two case studies with crossover AB interventions, two B-phase training designs, and three bi-phasic AB single-case designs with Start-Point and Order randomization (A = QG, B = LTQ). Study outcomes were measured using the System Usability Scale, UX interviews, and background analytics. LTQ’s usability levels were above the standard cutoff and on average higher than QG. UX outcomes suggested the relative benefits of LTQ’s visual design, gamification and simple design structure. LTQ’s overall UE was high; the app was opened for an average of 14 min per day (vs. QG: 7 min). However, users showed low levels of UE with each of the app’s tracking feature. Measures of psychiatric functioning suggested the safety of LTQ in people with SMI. LTQ appears to be a usable and engaging smoking cessation app in people with SMI. An optimized version of LTQ should be tested in a Phase II study.


BMJ Open ◽  
2020 ◽  
Vol 10 (6) ◽  
pp. e032675
Author(s):  
Marie K March ◽  
Alison Harmer ◽  
Emma Godfrey ◽  
Shruti Venkatesh ◽  
Bijoy Thomas ◽  
...  

IntroductionIncidence of total knee arthroplasty (TKA) is projected to rise 276% in 2030, and psychological distress affects up to 42% of people with knee osteoarthritis undergoing TKA, with demonstrated detrimental effects on postoperative outcomes. Few studies have assessed psychological treatment in people awaiting TKA, and these have been psychologist-delivered treatments. No evidence exists regarding psychologically-informed interventions delivered by health professionals currently embedded in TKA clinical pathways. The primary aim of this pilot study is to explore the safety, acceptability and feasibility of the Knee Osteoarthritis Management with Physiotherapy informed by Acceptance and Commitment Therapy (KOMPACT) approach in people awaiting TKA.Methods and analysis51 community-dwelling adults scheduled for a primary TKA at two hospitals will be recruited to this pilot, mixed-methods, prospective randomised controlled trial with assessor blinding. Participants will be randomised in a 1:2 ratio to either usual care (education class) or usual care plus KOMPACT (2 hours 20 min of preoperative physiotherapy informed by Acceptance and Commitment Therapy). Our primary outcome measures are safety (length of stay, complications and psychological health after KOMPACT), acceptability (treatment credibility and qualitative data) and feasibility (recruitment, retention and intervention fidelity) of the KOMPACT approach. Secondary outcomes include health service outcomes, patient-reported physical and psychological outcomes, and physical performance measures. Quantitative data collection was conducted at baseline, 1–2 weeks before TKA, 6 weeks after TKA and 6 months after TKA. Qualitative data collection is 1–2 weeks before TKA. Data analysis will take a quantitative-led approach with triangulation after thematic analysis of the qualitative data.Ethics and disseminationThis study has full ethics approval (HREC/18/WMEAD/440). Results from this study will be published in peer-reviewed journals and presented at local and international conferences.Trial registration numberAustralia New Zealand Clinical Trials Registry (ACTRN12618001867280p).


2021 ◽  
pp. 014544552110273
Author(s):  
Yors Garcia ◽  
Anastasia Keller-Collins ◽  
Meredith Andrews ◽  
Yukie Kurumiya ◽  
Kaleiya Imlay ◽  
...  

The purpose of this review was to quantitatively synthesize studies using acceptance and commitment therapy (ACT) with individuals with neurodevelopmental disorders (NNDs), their parents, and staff members that support them. Thirty studies published in peer-reviewed journals between 2006 and 2020 met inclusion criteria. They were reviewed and coded on variables associated with participants’ characteristics, settings, dropouts, design type, ACT procedures and measures, social validity, treatment integrity, and main findings. The What Works Clearinghouse (WWC), the revised Cochrane risk-of-bias tool for randomized trials (RoB2) and the Risk of Bias in Nonrandomized Studies of Interventions (ROBINS-I) were applied to evaluate the quality of the studies. Results indicated that 20 studies used group designs and 10 studies used single-case designs. Participants with NNDs consisted predominantly of those with autism spectrum disorder, attention deficit hyperactivity disorder, and learning disabilities. Group studies reported process and outcome measures exclusively; whereas, single-case studies also incorporated behavioral/direct measures. Overall, results showed mixed improvements across studies using indirect and direct measures. Lastly, quality assessment for group studies presented moderate or serious risk of bias and two single-case studies did not meet WWC evidence of effectiveness. Directions for future research and practice are discussed.


Sign in / Sign up

Export Citation Format

Share Document